Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
8.83
-0.11 (-1.23%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $92.72 million as of July 10, 2026. Its market cap has increased by 54.59% in one year.
Market Cap
92.72M
Enterprise Value
-30.97M
1-Year Change
54.59%
Ranking
Category
Stock Price
$8.83
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $92.72M, a decrease of -69.26%. That is a compound annual growth rate of -18.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 92.72M | 8.97% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 97.55M |
| Inovio Pharmaceuticals | 97.08M |
| Alterity Therapeutics | 96.07M |
| Biomea Fusion | 95.44M |
| Pelthos Therapeutics | 92.28M |
| Alps Group | 91.74M |
| Rein Therapeutics | 91.18M |
| Cardiff Oncology | 90.93M |